Arca Biopharma | ABIO - Le Bénéfice D'Exploitation

Prix De L'Action
61.93
Variation Quotidienne
-1.97 -3.08%
Mensuellement
-7.66%
Annuel
515.61%
Q2 Prévisions
63.25




Le Bénéfice D'Exploitation Changement Date
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.83B 130M 2026-03
Arca Biopharma USD -34.43M 326K 2025-12
Biogen USD 514.3M 128.8M 2026-03
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -181.23M 2.86M 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Otsuka Holdings JPY 118.21B 50.97B 2026-03
Pfizer USD 4.99B 340M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03